doi: 10.1016/S2213-8587(19)30249-9 [DOI] [PubMed] [Google Scholar] 67
These medications work by engaging the bodys own biology to help regulate appetite, blood sugar, and metabolic functionand theyre changing the way we approach not just weight loss, but also longevity
Since GLP-1 drugs were designed to fix insulin signaling in the body, they appear to fix the brains metabolism too, which helps it clear out toxic waste like amyloid
Exenatide (Byetta and Bydureon) Exenatide is currently marketed in two primary formulations: Byetta and Bydureon, representing the immediate-release and extended-release forms, respectively
A BMI of 30 is typically used as a cutoff for obesity, while 25 is used as the cutoff for overweight
Patients should maintain adequate hydration, especially if experiencing gastrointestinal side effects, to reduce the risk of acute kidney injury